Anthropic board director Vas Narasimhan bets AI can help Novartis solve ‘biological latency’
Fierce Biotech ·
In brief
Fierce Biotech reported on 20 Nov 2026: “Anthropic board director Vas Narasimhan bets AI can help Novartis solve ‘biological latency’”. This page links to the original article and to related American AI stories tracked by Deekoya AI.
- Source
- Fierce Biotech
- Published (IST)
Original reporting belongs to Fierce Biotech. DEEKOYA links the headline and a short excerpt only; we do not republish the full article.
Explore more: Today in AI · Research papers · AI tools · Learn AI
Related stories
- Nacionale
What is Anthropic? The company behind Claude, whose stock closed up 17% on its first day
NacionaleModelsUSA
- CX Today
Microsoft’s Contact Center AI Is All Consumption, No Commitment
CX TodayAIUSA
CNBC
Anthropic was supposed to save the AI trade. What went wrong?
CNBCAIUSA
- Digital Watch Observatory
Anthropic lists on Nasdaq amid catastrophic AI risk warnings
Digital Watch ObservatorysafetyUSA
- Crypto Briefing
Menlo Ventures’ Matt Murphy on Anthropic’s record IPO and ‘selling intelligence’
Crypto BriefingFundingUSA
- The Real Deal
Anthropic lifted SF office market pre-IPO, stand by for resi effect after $81B debut
The Real DealFundingUSA
Who reported “Anthropic board director Vas Narasimhan bets AI can help Novartis solve…”?
Fierce Biotech, on 20 Nov 2026. The full article is at the source link on this page.
Comments
No comments yet. Share your own experience below.
Visitor posts are moderated before they appear and are the opinion of their authors, not DEEKOYA AI. Names are not verified. See our privacy policy.